Xtl Biopharmaceuticals (XTLB) EBIT (2009 - 2024)
Xtl Biopharmaceuticals (XTLB) posted quarterly EBIT of -$2.1 million for Q4 2024, down 60.53% year-on-year from -$5.4 million in Q1 2024, and down 209.15% on a QoQ basis from $2.0 million in Q3 2024.
Xtl Biopharmaceuticals (XTLB) EBIT (2009 - 2024) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported EBIT for 16 consecutive years, with -$2.1 million the latest figure, recorded in Q4 2024.
- Quarterly EBIT fell 60.53% year-over-year to -$2.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$775000.0 (down 1.31% YoY) and the FY2025 annual result came in at -$1.7 million, down 117.81% from the prior year.
- EBIT eased to -$2.1 million in Q4 2024 per XTLB's latest filing, from $2.0 million in the prior quarter.
- Over the last five years, EBIT for XTLB reached as high as $2.0 million in Q3 2024 and fell as low as -$2.1 million in Q4 2024.
- A 5-year average of -$194250.0 and a median of -$224500.0 in 2020 frame the typical range for EBIT.
- The largest YoY upside for EBIT was 689.86% in 2021 against a maximum downside of 591.05% in 2021.
- Year by year, EBIT stood at -$257000.0 in 2020, then plunged by 591.05% to -$1.8 million in 2021, then rose by 13.57% to -$1.5 million in 2022, then gained by 13.36% to -$1.3 million in 2023, then sank by 60.53% to -$2.1 million in 2024.
- According to Business Quant data, EBIT over the past three periods registered -$2.1 million, $2.0 million, and -$771000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.14 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | -771,000.00 |
| Mar 31, 2024 | 175,000.00 |
| Dec 31, 2023 | -1.33 Mn |
| Sep 30, 2023 | 979,000.00 |
| Jun 30, 2023 | -163,000.00 |
| Mar 31, 2023 | -251,000.00 |
| Dec 31, 2022 | -1.54 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | -202,000.00 |
| Mar 31, 2022 | -249,000.00 |
| Dec 31, 2021 | -1.78 Mn |
| Sep 30, 2021 | 1.28 Mn |
| Jun 30, 2021 | -303,000.00 |
| Mar 31, 2021 | -232,000.00 |
| Dec 31, 2020 | -257,000.00 |
| Sep 30, 2020 | -217,000.00 |
| Jun 30, 2020 | -217,000.00 |
| Mar 31, 2020 | 257,000.00 |